To our knowledge, this is the first case of SLMNs and undifferentiated sarcoma after treatment of ovarian mucinous cystadenocarcinoma of the ovary with KRAS, TP53, MLL2 and NF1 mutation. Here, NF1 is linked to ovarian mucinous cystadenocarcinoma.